VeriMomtipa-lauroyl sarcosinate est-il sûr pendant la grossesse ?
Authoritative dossiers for lauroyl/sarcosinate category members (representative: sodium N‑lauroylsarcosinate) include an OECD 414 prenatal developmental study and long‑term reproductive/2‑year studies reporting no developmental/reproductive effects at doses up to and including high NOAELs; there is no harmonised CLP reproductive classification (ECHA registration dossiers show no H360/H361). PubMed/peer‑reviewed work on lauroyl sarcosinate does not identify reproductive/teratogenic effects. (Sources: ECHA registration dossiers; OECD414 summary in registration; PubMed literature.)
Pregnancy-safe products containing tipa-lauroyl sarcosinate
Related ingredients
Frequently asked questions
- tipa-lauroyl sarcosinate est-il sûr pendant la grossesse ?
- Authoritative dossiers for lauroyl/sarcosinate category members (representative: sodium N‑lauroylsarcosinate) include an OECD 414 prenatal developmental study and long‑term reproductive/2‑year studies reporting no developmental/reproductive effects at doses up to and including high NOAELs; there is no harmonised CLP reproductive classification (ECHA registration dossiers show no H360/H361). PubMed/peer‑reviewed work on lauroyl sarcosinate does not identify reproductive/teratogenic effects. (Sources: ECHA registration dossiers; OECD414 summary in registration; PubMed literature.)
- tipa-lauroyl sarcosinate est-il sûr pendant l'allaitement ?
- No evidence in registration dossiers or peer‑reviewed literature that lauroyl sarcosinates cause reproductive or lactation hazards or have mechanisms that would predict milk transfer or developmental toxicity. With topical cosmetic use (primarily rinse‑off surfactant), systemic exposure is expected to be negligible. (Sources: ECHA registration summaries; PubMed literature.)
- tipa-lauroyl sarcosinate est-il sûr pour la peau de bébé ?
- The ingredient is a mild anionic surfactant used in cleansers; authoritative safety dossiers for lauroyl sarcosinates support cosmetic use and do not indicate intrinsic developmental/reproductive hazard. For baby skin (0–3 yr) increase exposure score by +1 because infant skin has an immature barrier and higher surface‑area‑to‑weight, so low but measurable dermal absorption from rinse‑off/wash products is plausible even when adult systemic exposure is negligible. There is some consumer guidance and EWG notes about nitrosamine contamination risk for this class (cosmetic formulation/contaminant concern), but not reproductive toxicity. (Sources: ECHA registration summaries; CosIng/Cosmetic ingredient listings; EWG notes.)
- Comment VeriMom évalue-t-il tipa-lauroyl sarcosinate ?
- VeriMom évalue tipa-lauroyl sarcosinate à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à tipa-lauroyl sarcosinate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à tipa-lauroyl sarcosinate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.